Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Morgan

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI TrialSarah Bird, David Cairns, Tom Menzies, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 29, 2019
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomesMeera Mohan, Sandra Susanibar-Adaniya, Amy Buros, et al.
Lancet (London, England)|June 26, 2007
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trialMomodou K Darboe, David I Thurnham, Gareth Morgan, et al.
British Journal of Haematology|November 19, 2014
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasoneGareth Morgan, Antonio Palumbo, Sujith Dhanasiri, et al.
Research Square|August 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 25, 2018
Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experienceGareth Morgan, Pimpak Prachasilchai, Worakan Promphan, et al.
Bioinformatics (Oxford, England)|July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence dataEran Elhaik, Sara Behnamian, Michael Howe, et al.
BJR Open|September 15, 2022
Radiologist opinions regarding reporting incidental coronary and cardiac calcification on thoracic CTMichelle C Williams, Jonathan Weir-McCall, Alastair J Moss, et al.
Leukemia|June 22, 2018
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trialsJennifer L J Heaney, John P Campbell, Gulnaz Iqbal, et al.
Haematologica|November 21, 2007
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myelomaGösta Gahrton, Simona Iacobelli, Giuseppe Bandini, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI TrialSarah Bird, David Cairns, Tom Menzies, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 29, 2019
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomesMeera Mohan, Sandra Susanibar-Adaniya, Amy Buros, et al.
Lancet (London, England)|June 26, 2007
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trialMomodou K Darboe, David I Thurnham, Gareth Morgan, et al.
British Journal of Haematology|November 19, 2014
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasoneGareth Morgan, Antonio Palumbo, Sujith Dhanasiri, et al.
Research Square|August 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 25, 2018
Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experienceGareth Morgan, Pimpak Prachasilchai, Worakan Promphan, et al.
Bioinformatics (Oxford, England)|July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence dataEran Elhaik, Sara Behnamian, Michael Howe, et al.
BJR Open|September 15, 2022
Radiologist opinions regarding reporting incidental coronary and cardiac calcification on thoracic CTMichelle C Williams, Jonathan Weir-McCall, Alastair J Moss, et al.
Leukemia|June 22, 2018
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trialsJennifer L J Heaney, John P Campbell, Gulnaz Iqbal, et al.
Haematologica|November 21, 2007
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myelomaGösta Gahrton, Simona Iacobelli, Giuseppe Bandini, et al.
Pageof 23